The BCG (bacille Calmette-Guerin) vaccine is a vaccine used to protect against tuberculosis (TB). It is an attenuated (weakened) form of the bacterium that causes TB, and it is given by injection. The BCG vaccine is the most widely used vaccine against TB. It is given to babies and young children in many countries, and is recommended in countries with a high prevalence of TB. It is also recommended for people who are at high risk of TB infection, such as healthcare workers and people with HIV. The BCG vaccine is considered to be safe and effective in preventing TB, but its effectiveness does vary from one population to another.
The BCG vaccine, short for Bacillus Calmette–Guérin vaccine, is primarily used to prevent tuberculosis (TB), a serious infectious disease that mainly affects the lungs. Here's a detailed description of the BCG vaccine:
Purpose:
- Provides partial protection against TB, particularly severe forms like tuberculous meningitis and miliary TB in children.
- Offers limited protection against adult pulmonary TB, the most common form.
Administration:
- Given as a single dose through intradermal injection, typically in the upper arm.
- Recommended for infants and children in high TB prevalence countries.
- Not routinely recommended in countries with low TB rates like the US due to:
- Low infection risk.
- Variable vaccine effectiveness against adult TB.
- Potential interference with TB skin tests.
Efficacy:
- Effectiveness varies geographically, ranging from 60-80% protection in some regions to no significant protection in others.
- Overall, the World Health Organization (WHO) estimates 50% protection against TB in children.
Considerations:
- Not recommended for:
- Pregnant women.
- Individuals with weakened immune systems (immunosuppressed).
- People with a positive tuberculin skin test (TST), indicating potential TB exposure.
- May cause mild side effects like:
- Injection site redness, swelling, or scar.
- Low-grade fever.
- Swollen lymph nodes.